Searching News Database: Geron Corp
HSMN NewsFeed - 8 May 2018
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
Pliant Therapeutics Appoints Hoyoung Huh as Chairman and Éric Lefebvre as Chief Medical Officer
HSMN NewsFeed - 19 Apr 2013
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
BioTime Enters into Worldwide License Agreement with UCLA to Develop Therapy for the Treatment of Stroke
HSMN NewsFeed - 6 Mar 2012
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors
CytomX Therapeutics Appoints Hoyoung Huh, M.D., Ph.D., Chairman of Board of Directors
HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
HSMN NewsFeed - 25 Jan 2008
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
Dr. Thomas Okarma Resumes Direct Leadership of Geron's Oncology Drug Development Activities
HSMN NewsFeed - 23 Oct 2007
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
BioTime Names Robert W. Peabody Senior Vice President and Chief Operating Officer
HSMN NewsFeed - 11 Jul 2007
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
Geron Initiates Clinical Trial of Telomerase Cancer Vaccine in Patients with Acute Myelogenous Leukemia
HSMN NewsFeed - 17 Jan 2007
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
Studies Show Geron's Stem Cell Therapeutic for Spinal Cord Injury Produces Nerve Growth Factors
HSMN NewsFeed - 6 Nov 2006
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
Geron Licenses Antigen Targeting Patents for Cancer Vaccine Program from Immunomic Therapeutics
HSMN NewsFeed - 22 Jun 2006
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
Geron Announces Collaboration to Develop Synthetic Surfaces for Growth of Embryonic Stem Cells
HSMN NewsFeed - 18 May 2006
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Geron Names Laurence Elias, M.D., Vice President, Oncology Clinical Development
Additional items found! 26
Members Archive contains
26 additional stories matching:
Geron Corp
(Password required)
Geron Corp
(Password required)